In 2003, VaxGen, a San Francisco-based biotechnology company, announced that its AIDSVAX vaccine trial had not reduced HIV infection rates among those who were vaccinated. On April 4 of that year, Worldview spoke to Bob Elliot, a college student who co-founded the Student Global AIDS Campaign. The Campaign still exists and last year launched a campaign called “PrEP for the Future,” which aims to increase the accessibility of pre-exposure prophylaxis. They also advocate for the U.S. to increase its funding contribution to the AIDS programs PEPFAR and the Global Fund.
Special thanks to the WBEZ Archives Team for cataloging 25 years of Worldview and making this segment possible.